Keiji Sugiyama

Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma

Motoo Nagane, Ryo Nishikawa, Yusuke Narita et al. · Japanese Journal of Clinical Oncology · 2012 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer

Kazunori Honda, Bishal Gyawali, Masashi Ando et al. · Journal of Global Oncology · 2019 · 89 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer

Keiji Sugiyama, Yukiya Narita, Seiichiro Mitani et al. · Anticancer Research · 2018 · 58 citations · Full text

Medicine, Oncology, Pharmacology +15

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study

Kazunori Honda, Bishal Gyawali, Masashi Ando et al. · ecancermedicalscience · 2018 · 56 citations · Full text

Pharmacy, Oncology, Chemotherapy +16

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

Toshiki Masuishi, Shigenori Kadowaki, Mayumi Kondo et al. · Anticancer Research · 2017 · 40 citations

Medicine, Oncology, Pharmacology +14